XP Power Ltd (XPP)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 1,706.00 |
|---|---|
| 52-week range | 849.23 – 2,160.00 |
| Return, 1 month / 3 months | −16.8% / −3.2% |
| Return, 1 year / 3 years | +63.4% / +68.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 44.2% |
| Worst drawdown (1 year) | -21.9% |
| Average daily value traded | 189.76M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
XP Power designs and manufactures power supplies and related components for equipment makers. Its products include AC-DC power supplies, DC-DC converters and high-voltage supplies used in healthcare, industrial, semiconductor and technology applications. The company works with original equipment manufacturers that need reliable power conversion inside their machines. XP Power is based in Singapore and runs design, manufacturing and sales operations in several countries, serving customers across Asia, Europe and North America.
XP Power Ltd trades under the code XPP on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
XP Power Ltd (XPP) trades on the London Exchange in UK. It last closed at GBX 1,706.00 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 669 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 63.4% and over the last three months it fell 3.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.7% | ||
| From 52-week high | -18.8% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -3.2% | ||
| 6-month return | 15.6% | ||
| 12-month return, skipping the last month | 96.4% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.9% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 189.76M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −10.3% |
|---|---|
| 1 month | −16.8% |
| 3 months | −3.2% |
| 6 months | +15.6% |
| 1 year | +63.4% |
| 3 years | +68.9% |
| 5 years | −64.8% |
Signals
| 50-day / 200-day average | 1,885.70 / 1,645.64 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 105.06 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Sep 2023 | GBP 0.1900 |
| 15 Jun 2023 | GBP 0.1800 |
| 23 Mar 2023 | GBP 0.3600 |
| 8 Dec 2022 | GBP 0.2100 |
| 8 Sep 2022 | GBP 0.1900 |
| 16 Jun 2022 | GBP 0.1800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.